user

Trastuzumab plus paclitaxel in HER-2 positive metastatic breast cancer: A single institutional experience

被引：0
|
作者：
Capobianco, A. M. L. [1 ]
Di Leo, P. [1 ]
Bochicchio, A. M. [1 ]
Coccaro, M. [1 ]
Romano, G. [1 ]
Tartarone, A. [1 ]
Ardito, R. [1 ]
Musto, C. [1 ]
Barone, M. [1 ]
Guarigli, R. [1 ]
Di Renzo, N. [1 ]
机构：
[1] Reg Hosp, Ctr Riferimento Oncol Basilicata, Div Hematol Oncol, Rionero In Vulture, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [1] Lapatinib plus trastuzumab for HER-2 positive metastatic breast cancer: experience of use
    Garcia Munoz, C.
    Cortijo Cascajares, S.
    Canamares Orbis, I.
    Goyache Goni, M. D. P.
    Ferrari Piquero, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 892 - 893
  • [2] Trastuzumab plus Paclitaxel in HER2-positive Breast Cancer
    不详
    GYNAKOLOGE, 2016, 49 (08): : 558 - 558
  • [3] Docetaxel plus trastuzumab as treatment for HER-2 positive metastatic breast cancer: review of the existing evidence
    Demonty, Gaston
    WOMENS HEALTH, 2007, 3 (05) : 523 - 528
  • [4] Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer
    Andrew D. Seidman
    Larry Norton
    Current Oncology Reports, 2005, 7 (1) : 9 - 11
  • [5] Weekly paclitaxel and trastuzumab as first-line chemotherapy in patients with her-2 positive metastatic breast cancer
    Kim, Jin-Soo
    Han, Hye-Suk
    Im, Seock-Ah
    Oh, Do-Youn
    Han, Won-Shik
    Lee, Se-Hoon
    Kim, Dong-Wan
    Kim, Tae-You
    Noh, Dong-Young
    Bang, Yung-Jue
    ANNALS OF ONCOLOGY, 2006, 17 : 85 - 85
  • [6] Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer
    Yu, Anthony F.
    Manrique, Carlos
    Pun, Shawn
    Liu, Jennifer E.
    Mara, Elton
    Fleisher, Amartin
    Patil, Sujata
    Jones, Lee W.
    Steingart, Richard M.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGIST, 2016, 21 (04): : 418 - 424
  • [7] Trastuzumab use beyond progression on previous trastuzumab treatment in HER-2 positive metastatic breast cancer
    Hutka, Margaret M.
    Kolosza, Zofia
    Utracka-Hutka, Beata
    ANNALS OF ONCOLOGY, 2007, 18 : 163 - 163
  • [8] TRASTUZUMAB BEYOND PROGRESSION IN PATIENTS WITH HER-2/NEU POSITIVE METASTATIC BREAST CANCER
    Eralp, Yesim
    JOURNAL OF BREAST HEALTH, 2009, 5 (01): : 3 - 8
  • [9] Gemcitabine, paclitaxel plus trastuzumab (GTH) in HER2 ECD-positive metastatic breast cancer.
    Colomer, R
    Mayordomo, JI
    Calvo, L
    Hornedo, J
    Carabantes, F
    Gil, M
    Martin, B
    Cortes-Funes, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 61S - 61S
  • [10] HER2 ECD-positive metastatic breast cancer treated with gemcitabine, paclitaxel plus trastuzumab (GTH)
    Colomer, R
    Mayordomo, JI
    Calvo, L
    Hornedo, J
    Carabantes, F
    Gil, M
    Cortes-Funes, H
    Martin, B
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S127 - S128
12345